Диссертация (1139920), страница 16
Текст из файла (страница 16)
– Chisinau, 2007.159. Nishimura N., Umeda C., Oda H., Yokogoshi H. The effect of taurineon the cholesterol metabolism in rats fed dietssupplemented with cholestyramineor high amounts of bile acid // J. Nutr. Sci. Vitaminol. – 2003. - Vol. 49. - P. 2126.160. Nishio H., Terashima S., Nakashima M. et al.
Involvement of111prostaglandin E receptor EP3 subtype and prostacyclin IP receptor in decreasedacid response in damaged stomach // J. Physiol. Pharmacol. - 2007. - Vol. 58 (3).- P. 407-421.161. Ochoa-de la Paz L. D., Martinez-Davila I. A., Miledi R. et al.Modulation of human GAB- Arho 1 receptors by taurine // Neurosci. Res. - 2008.- Vol. 61 (3). - P. 302-308.162. Ogawa M., Takahara A., Ishijima M., Tazaki S. Decrease of plasmasulfur amino acids in essential hypertension // Jpn. Circ. J. – 1985.
– Vol. 49. –P.1217 -1224.163. Orlova T.R., Elizarova E.P., Ryff I.M. et al. Use of taurine in thetreatment of experimental congestive heart failure // Kardiologiia. -1991. –Vol.31. – P.77-80.164. Oudit G.Y., Trivieri M.G., Khaper N. et al. Taurine supplementationreduces oxidative stress and improves cardiovascular function in an iron-overloadmurine model // Circulation. - 2004. – Vol.109. – P.1877-1885.165.
Parikh M.C., Patel S.N., Shen Y., Lau-Cam C.A. Role of taurine onthe actions of alcohol against systemic and cardiac biochemical changes in thediabetic rat // Adv. Exp. Med. Biol. – 2015. – Vol.803. – P.313-338.166. Parildar H., Dogru-Abbasoglu S., Mehmetcik G. et al. Lipidperoxidation potential and antioxidants in the heart tissue of beta-alanine- ortaurine-treated old rats // J. Nutr. Sci Vitaminol. – 2008. - Vol.54. – P.61–65.167. Pennathur S., Heinecke J.W.
Oxidative stress and endothelialdysfunction in vascular disease // Curr. Diab. Rep. - 2007. - Vol. 7. - P.257–264.168.Peterson M.B., Mead R.J., Welty J.D. Free amino acids in congestiveheart failure // J. Mol. Cell Cardiol. - 1973. – Vol.5. – P.139-147.169. Petrov G., Regitz-Zagrosek V., Lehmkuhl E. et al. Regression ofmyocardial hypertrophy after aortic valve replacement: faster in women?//Circulation. – 2010. – Vol. 122.
– P.23–28.170. Rahman M.M., Park H.M., Kim S.J. et al. Taurin preventshypertension and increases exercise capacity in rats with fructose-induced112hypertension // Am. J. Hypertens. - 2011. – Vol. 24. – P.574-581.171. Rahmeier F.L., Zavalhia L.S., Tortorelli L.S. et al. The effectof taurine and enriched environment on behaviour, memory and hippocampus ofdiabetic rats // Neurosci Lett.. - 2016. – Vol.630. – P.84-92.172.
Rakotoambinina B., Marks L., Badran A.M. et al. Taurine kineticsassessed using [1,2-13C2]taurine in healthy adult humans // AJP: Endocrinol.Metab. - 2004. - Vol. 287. - P. 255- P.262.173. Ramila K.C., Jong C.J., Pastukh V. et al. Role of proteinphosphorylation in excitation-contraction coupling in taurine deficient hearts //Am.
J. Physiol. Heart Circ. Physiol. - 2015. – Vol.308 (3). – P.232-239.174. Rikimaru M., Ohsawa Y., Wolf A. et al. Taurine AmelioratesImpaired the Mitochondrial Function and Prevents Stroke-like Episodes in Patientswith MELAS // Intern. Med. – 2012. – Vol.51 (24). – P.3351-3357.175. Roysommuti S., Malila P., Lerdweeraphon W. et al. Perinatal taurineexposure alters renal potassium excretion mechanisms in adult conscious rats // J.Biomed. Sci. - 2010. – Vol.17, Suppl.1. – P.29.176. Sahin M.A., Yucel O., Guler A.
et al. Is there any cardioprotectiverole of Taurine during cold ischemic period following global myocardial ischemia?// J. Cardiothorac. Surg. – 2011. - Mar 18;6:31.177. Sakmann B., Noma A., Trautwein W. Acetylcholine activation ofsingle muscarinic K + channels in isolated pacemaker cells of the mammalian heart// Nature. - 1983. - Vol.303. - P. 250-253.178.Schaffer S.W., Azuma J. Review: myocardial physiological effects oftaurine and their significance // Adv.
Exp. Med. Biol. - 1992. – Vol. 315. – P.105–120.179. Schaffer S.W., Azuma J., Mozaffari M. Role of antioxidant activity oftaurine in diabetes // Can. J. Physiol. Pharmacol. - 2009. – Vol. 87. – P.91-99.180. Schaffer S.W., Shimada K., Jong C.J. et al. Effect of taurine andpotential interactions with caffeine on cardiovascular function // Amino Acids.
2014. – Vol.46 (5). – P.1147-1157.113181. Schaffer S.W., Jong C.J., Ito T., Azuma J. Effect of taurine onischemia reperfusion injury // Amino Acids. – 2014. – Vol. 46. – P.21–30.182. Schaffer S.W., Ramila K.C., Jong C.J. et al. Does taurine prolonglifespan by improving heart function? // Adv. Exp. Med. Biol. – 2015. – Vol.803.– P.555-570.183. Schaffer S.W., Shimada-Takaura K., Jong C.J. et al.
Impaired energymetabolism of the taurine-deficient heart // Amino Acids. – 2016. – Vol.48 (2). –P.549-558.184. Schuller-Levis G.B., Park E. Taurine: new implications for an oldamino acid // FEMS Microbiol Lett. - 2003. – Vol.226. – P.195-202.185. Sener G., Ozer Sehirli A., Ipçi Y. et al. Taurine treatment protectsagainst chronic nicotine-induced oxidative changes // Fundam. Clin. Pharmacol. 2005. – Vol.19. – P.155-164.186.
Shimada K., Jong C.J., Takahashi K., Schaffer S.W. Role of ROSProduction and Turnover in the Antioxidant Activity of Taurine // Adv. Exp. Med.Biol. – 2015. – Vol.803. – P.581-596.187. Shiohira S., Komatsu M., Okazaki M. et al. Effect of Taurine onHemodiafiltration in Patients With Chronic Heart Failure // Ther. Apher. Dial. –2016. – Vol.20 (1). – P.20-26.188. Sinakos E., Lindor K. D. Bile acid profiles in intrahepatic cholestasisof pregnancy: is this the solution to the enigma of intrahepatic cholestasis ofpregnancy? // Am. J. Gastroenterol. - 2010.
- Vol. 105 (3). - P.596-598.189. Sinha M., Manna P., Sil P.C. Taurine protects the antioxidant defensesystem in the erythrocytes of cadmium treated mice // BMB Reports. - 2008. –Vol.41 (9). – P.657-663.190. Soukoulis V., Dihu J.B., Sole M. et al. Micronutrient deficiencies anunmet need in heart failure // J. Am. Coll. Cardiol. - 2009. – Vol.54. – P.16601673.191. Stevens M.
J., Hosaka Y., Masterson J. A. et al. Downregulation ofthe human taurine transporter by glucose in cultured retinal pigment epithelial cells114// AJP: Endocrinol. Metab. - 2009. - Vol. 277. - P.760-771.192. SuarezL.M.,MunozM.D.,GonzalezJ.C.etal.The taurine transporter substrate guanidinoethyl sulfonate mimics the actionof taurine on long-term synaptic potentiation // Amino Acids. - 2016.
- Jul 15.[Epub ahead of print]193. Suarez L.M., Munoz MD, Martin Del Rio R., Solis J.M.Taurine content in different brain structures during ageing: effect on hippocampalsynaptic plasticity //Amino Acids. - 2016. – Vol.48 (5). – P.1199-1208.194. Suleiman M.S., Fernando H.C., Dihmis W.C. et al.
A loss of taurineand other amino acids from ventricles of patients undergoing bypass surgery // Br.Heart J. – 1993. - Vol.69. – P.241–245.195. Suleiman M.S., Zacharowski K., Angelini G.D. Inflammatoryresponse and cardioprotection during open-heart surgery: the importance ofanaesthetics // Br. J. Pharmacol. – 2008. - Vol.153. – P.21–33.196. Suleiman M.S., Hancock M., Shukla R. et al. Cardioplegic strategiesto protect the hypertrophic heart during cardiac surgery // Perfusion.
– 2011. Vol.26 (Suppl.1). – P.48–56.197. Takashi I., Stephen W. Schaffer and Junichi Azuma. The potentialusefulness of taurine on diabetes mellitus and its complications // Amino Acids. 2012. - Vol. 42 (5). - P.1529–1539.198. Takatani T., Takahashi K., Uozumi Y. et al. Taurine prevents theischemia-induced apoptosis in cultured neonatal rat cardiomyocytes throughAkt/caspase-9 pathway // Biochem. Biophys. Res.
Commun. – 2004. - Vol.316. P.484–489.199. Takihara K., Azuma J., Awata N. et al. Beneficial effect of taurine inrabbits with chronic congestive heart failure // Am. Heart J. - 1986. – Vol.112. –P.1278-1284.200. Tappaz M.L. Taurine biosynthetic enzymes and taurine transporter:molecular identification and regulations // Neurochem. Res.
- 2004. - Vol. 29. –P.83-96.115201. Tappia P.S., Thliveris J., Xu Y.J. et al.Effects of amino acidsupplementation on myocardial cell damage and cardiac function in diabetes //Exp. Clin. Cardiol. – 2011. – Vol.16. – P.17–22.202. Tappia P.S., Xu Y.J., Rodriguez-Leyva D. et al. Cardioprotectiveeffects of cysteine alone or in combination with taurine in diabetes // Physiol.
Res.– 2013. – Vol. 62. – P.171–178.203. Terrill J.R., Duong M.N., Turner R. et al. Levels of inflammation andoxidative stress, and a role for taurine in dystropathology of the Golden RetrieverMuscular Dystrophy dog model for Duchenne Muscular Dystrophy // Redox Biol.- 2016. – Vol.30 (9). - P.276-286.204. Tong E.H., Guo J.J., Huang A.L. et al.Regulation ofnucleocytoplasmic trafficking of transcription factor OREBP/TonEBP/NFAT5 // J.Biol.
Chem. - 2006. – Vol.281. – P.23870–23879.205. Trautwein W., Kameyama M. Intracellular control of calcium andpotassium currents in cadiac cells // Jpn. Heart J. - 1986. - Vol.27. - P. 31-50.206. Ulrich-Merzenich G., Zeitler H., Vetter H., Bhonde R.R. Protectiveeffects of taurine on endothelial cells impaired by high glucose and oxidized lowdensity lipoproteins // Eur. J. Nutr. – 2007. – Vol. 46 (8). – P. 431–438.207. Van de Werf F., Crea F. The year in cardiology 2014: acute coronarysyndromes // Eur. Heart J.- 2015. – Vol. 36. – P. 342–346.208. Venturini A., Ascione R., Lin H.et al. The importance of myocardialamino acids during ischemia and reperfusion in dilated left ventricle of patientswith degenerative mitral valve disease // Mol.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
